Brief: Benitec Biopharma Releases Full Year 2025 Financial Results
22/09/2025 21:49
Sept 22 (Reuters) - Benitec Biopharma Inc BNTC.O: BENITEC BIOPHARMA RELEASES FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES OPERATIONAL UPDATE BENITEC BIOPHARMA: ENROLLMENT OF FIRST SUBJECT INTO COHORT 2 OF BB-301 PHASE 1B/2A TREATMENT STUDY EXPECTED IN Q4 2025 BENITEC BIOPHARMA- INTERIM CLINICAL STUDY RESULTS FOR BB-301 PHASE 1B/2A TREATMENT STUDY EXPECTED IN Q4 2025 Source text: ID:nGNX22zppS Further company coverage: BNTC.O ((Reuters.Briefs@thomsonreuters.com;))